Sector 10, Inc. (SECI) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 0.00 means the share price is 0.00 times one year of earnings per share.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSector 10, Inc. (SECI) trades at $0.0001. Sector 10, Inc. is a development stage company focused on marketing MRU SRU product lines and mobile asset solutions. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for SECI: SECI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Sector 10, Inc. (SECI) Healthcare & Pipeline Overview
Sector 10, Inc., established in 2002, operates as a development stage company within the medical instruments and supplies industry. It focuses on marketing MRU SRU product lines and mobile asset solutions. The company faces challenges typical of early-stage ventures in a competitive healthcare market.
What Is the Investment Thesis for SECI?
Sector 10, Inc. presents a high-risk, high-reward investment opportunity due to its development stage status and limited operational scale. The company's focus on MRU-SRU product lines and mobile asset solutions could address emerging needs in healthcare logistics and remote monitoring. However, the company's small size, as indicated by its two employees, and lack of revenue generation pose significant challenges. The company's high beta of 16675.40 indicates extreme volatility. Successful commercialization of its products and securing additional funding are critical for the company's survival. Investors should carefully consider the risks associated with investing in a development stage OTC company with limited resources and a lack of established market presence.
Based on FMP financials and quantitative analysis
SECI Key Highlights
Market capitalization of $0.00B indicates the company is a micro-cap or nano-cap stock.
- P/E ratio of 0.00 suggests the company is not currently profitable.
- Beta of 16675.40 indicates extremely high volatility compared to the market.
- No dividend yield reflects the company's current focus on reinvesting earnings for growth.
- Operating as a development stage company suggests a high degree of risk and potential for future growth.
Who Are SECI's Competitors?
SECI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| HSTC HST Global, Inc. | $0.10 | -85.71% | $14.1M | — |
| RDGT Ridgetech Inc. | $0.87 | +2.81% | 33 5-pillar | |
| ACH Accendra Health, Inc. | $0.51 | -9.43% | $38.7M | — |
| PBH Prestige Consumer Healthcare Inc. | $45.26 | +1.09% | $2.14B | 63 5-pillar |
| GRDN Guardian Pharmacy Services, Inc. | $42.38 | +3.77% | $2.68B | 97 5-pillar |
| HSIC Henry Schein, Inc. | $84.88 | -0.06% | $9.67B | 73 5-pillar |
| CAH Cardinal Health, Inc. | $228.30 | -0.78% | $53.5B | 88 5-pillar |
| COR Cencora, Inc. | $309.05 | -0.24% | $60.1B | 81 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SECI's Key Strengths?
Focus on niche market segments
- Potential for innovation in mobile asset solutions
- Proprietary MRU-SRU product lines
- Agility as a small company
What Are SECI's Weaknesses?
Limited financial resources
- Small team size (2 employees)
- Development stage company with no established revenue
- High beta indicating extreme volatility
What Are the Key Risks for SECI?
Negative return on equity (-0.1%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited financial resources may hinder growth and product development.
- Intense competition in the medical instruments and supplies industry.
- Stringent regulatory requirements may delay product approvals.
- Dependence on key personnel (2 employees) poses operational risks.
- High beta indicates extreme volatility and market sensitivity.
What Threats Does SECI Face?
- Intense competition in the healthcare industry
- Stringent regulatory requirements
- Technological obsolescence
- Economic downturn affecting healthcare spending
What Are SECI's Competitive Advantages?
- Proprietary MRU-SRU product lines
- Potential for innovation in mobile asset solutions for healthcare
- Early mover advantage in niche market segments
- Strategic partnerships with key healthcare stakeholders
What Does SECI Do?
Sector 10, Inc. was founded in 2002 and is based in Bellevue, Washington. The company operates as a development stage entity, primarily focused on marketing MRU SRU product lines and providing solutions related to mobile assets. As a development stage company, Sector 10, Inc. is likely in the early phases of product development and market entry. The company's focus on mobile asset solutions suggests potential applications within logistics, tracking, or remote monitoring. However, with only two employees, the scale of operations is currently limited. The company's success hinges on its ability to effectively commercialize its MRU-SRU product lines and establish a sustainable market presence. The healthcare industry is highly competitive and regulated, requiring significant investment in research, development, and regulatory compliance.
What Products and Services Does SECI Offer?
- Markets MRU SRU product lines.
- Provides solutions related to mobile assets.
- Operates as a development stage company.
- Focuses on the medical instruments and supplies industry.
- Aims to commercialize its product offerings.
- Provides solutions for healthcare logistics and remote monitoring.
How Does SECI Make Money?
- Focuses on developing and marketing MRU-SRU product lines.
- Generates revenue through the sale of mobile asset solutions.
- Aims to establish partnerships within the healthcare sector.
- Pursues opportunities in remote patient monitoring and diagnostics.
What Industry Does SECI Operate In?
Sector 10, Inc. operates within the medical instruments and supplies industry, a segment characterized by continuous innovation and stringent regulatory oversight. The industry is driven by technological advancements, aging populations, and increasing demand for healthcare services. Competition is intense, with established players like Medtronic and Johnson & Johnson dominating the market. Smaller companies like Sector 10, Inc. must differentiate themselves through niche products or innovative solutions to gain market share. The industry is also subject to evolving regulatory requirements, impacting product development and market access.
Who Are SECI's Key Customers?
- Hospitals and clinics
- Healthcare providers
- Medical research institutions
- Logistics companies in the healthcare sector
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Sector 10, Inc. operates in the Healthcare sector. It is headquartered in Bellevue, US. The company is led by CEO Pericles DeAvila. SECI has traded publicly since 2006.
Key Financial Metrics
Return on equity for Sector 10, Inc. stands at -0.1%, a gauge of how efficiently it converts shareholder capital into profit. SECI trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~21.10x. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Sector 10, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Insider Activity
10 transactions · 0 purchases, 0 sales, 10 other transactions · 2 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
SECI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
SECI Latest News
No recent news available for SECI.
SECI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SECI.
Price Targets
Wall Street price target analysis for SECI.
SECI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SECI; grades run from A+ (80-100) to F (below 30).
Leadership: Pericles DeAvila
Managing Director
Pericles DeAvila serves as the Managing Director of Sector 10, Inc. His responsibilities include overseeing the company's operations and guiding its strategic direction. Given the company's small size, his role likely encompasses a wide range of functions, from product development to marketing and sales.
Track Record: Due to the limited information available and the company's development stage, it is difficult to assess Pericles DeAvila's track record. The success of Sector 10, Inc. will depend on his ability to secure funding, commercialize its products, and establish a sustainable market presence. His leadership will be crucial in navigating the challenges of a competitive healthcare market.
SECI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by the least stringent listing requirements and the highest level of risk. Companies in this tier may not meet the minimum financial standards required for listing on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to limited regulation, potential for fraud, and lack of transparency. These companies often have minimal operating history, limited assets, and unproven business models. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited financial resources and operating history
- Lack of regulatory oversight and transparency
- Potential for fraud and manipulation
- High volatility and illiquidity
- Uncertainty regarding the company's business model and prospects
- Verify the company's registration and legal status
- Obtain and review audited financial statements
- Assess the company's management team and their experience
- Evaluate the company's business model and market opportunity
- Understand the risks associated with investing in OTC stocks
- Consult with a qualified financial advisor
- Check for any regulatory actions or legal proceedings
- Company was founded in 2002
- Focus on healthcare-related solutions
- Presence of a CEO/Managing Director
Common Questions About SECI (Healthcare)
What does Sector 10, Inc. do?
Sector 10, Inc. is a development stage company that focuses on marketing MRU-SRU product lines and providing mobile asset solutions within the healthcare sector.
What do analysts say about SECI stock?
As of March 18, 2026, there is no available analyst coverage for Sector 10, Inc. due to its OTC listing and development stage status. Key valuation metrics, such as price targets and earnings estimates, are not available.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's OTC status and development stage.
- Financial data is based on available information and may not be comprehensive.